BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8838759)

  • 21. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
    Bae KT; Zhu F; Chapman AB; Torres VE; Grantham JJ; Guay-Woodford LM; Baumgarten DA; King BF; Wetzel LH; Kenney PJ; Brummer ME; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):64-9. PubMed ID: 17699192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency and clinical profile of patients with polycystic kidney disease in southern Brazil.
    Nunes AC; Milani V; Porsch DB; Rossato LB; Mattos CB; Roisenberg I; Barros EJ
    Ren Fail; 2008; 30(2):169-73. PubMed ID: 18300116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications.
    Taylor M; Johnson AM; Tison M; Fain P; Schrier RW
    Am J Kidney Dis; 2005 Sep; 46(3):415-23. PubMed ID: 16129202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
    Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
    Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality.
    Perrone RD; Ruthazer R; Terrin NC
    Am J Kidney Dis; 2001 Oct; 38(4):777-84. PubMed ID: 11576881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.
    Christophe JL; van Ypersele de Strihou C; Pirson Y
    Nephrol Dial Transplant; 1996 Jul; 11(7):1271-6. PubMed ID: 8672022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two cases of autosomal dominant polycystic kidney disease treated with hemodialysis associated with polycystic liver complications related to the cause of death].
    Saima S; Suzuki Y; Yoshimoto K; Nakamura Y; Munakata A
    Nihon Jinzo Gakkai Shi; 1996 Jun; 38(6):278-84. PubMed ID: 8752971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of kidney transplantation in patients with polycystic kidney disease: a single center study.
    Roozbeh J; Razmkon AR; Jalaeian H; Raiss-Jalali GA; Behzadi S; Sagheb MM; Salahi H; Bahador A; Nikeghbalian S; Davari HR; Salehipour M; Malek-Hosseini SA
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):72-5. PubMed ID: 18087127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension in autosomal dominant polycystic kidney disease: observational study in 207 patients with a mean follow-up of 107 months.
    De Almeida EA; Prata MM
    Rev Port Cardiol; 2007 Nov; 26(11):1173-82. PubMed ID: 18297839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autosomal dominant polycystosis in the hospital milieu in Dakar (Senegal)].
    Diouf B; Dia D; Ka MM; Ka EF; Diop TM
    Dakar Med; 1998; 43(2):205-8. PubMed ID: 10797964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure.
    Hajj P; Ferlicot S; Massoud W; Awad A; Hammoudi Y; Charpentier B; Durrbach A; Droupy S; Benoît G
    Urology; 2009 Sep; 74(3):631-4. PubMed ID: 19616833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are large nonfunctional kidneys risk factors for posttransplantation urinary tract infection in patients with end-stage renal disease due to autosomal dominant polycystic kidney disease?
    Salehipour M; Jalaeian H; Salahi H; Bahador A; Davari HR; Nikeghbalian S; Sagheb MM; Raiss-Jalali GA; Roozbeh J; Behzadi S; Janghorban P; Sepas HN; Malek-Hosseini SA
    Transplant Proc; 2007 May; 39(4):887-8. PubMed ID: 17524840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver cysts in Congolese patients with autosomal dominant polycystic kidney disease follow a family pattern.
    Assounga AG; Yacoubou Y; Makosso E; Ibara JR; Gombet T
    S Afr Med J; 2003 Jul; 93(7):542-4. PubMed ID: 12939930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
    Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic linkage analysis, clinical features and prognosis of autosomal dominant polycystic kidney disease in Northern Ireland.
    Wright GD; Hughes AE; Larkin KA; Doherty CC; Nevin NC
    Q J Med; 1993 Jul; 86(7):459-63. PubMed ID: 8210302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
    Mosetti MA; Leonardou P; Motohara T; Kanematsu M; Armao D; Semelka RC
    J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autosomal dominant polycystic kidney disease: new information for genetic counselling.
    Bear JC; Parfrey PS; Morgan JM; Martin CJ; Cramer BC
    Am J Med Genet; 1992 Jun; 43(3):548-53. PubMed ID: 1605247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
    Magistroni R; Manfredini P; Furci L; Ligabue G; Martino C; Leonelli M; Scapoli C; Albertazzi A
    J Nephrol; 2003; 16(1):110-5. PubMed ID: 12653106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.